DiabTec Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
DiabTec General Information
Description
Manufacturer of recombinant human Insulin active pharmaceutical ingredient (API) intended to serve the life sciences sector. The company offers large-scale drug substance reactors and cartridge fill-finish facilities, enabling the MENA region and the UAE's life sciences sector to enhance local manufacturing, strengthen supply chain sustainability, and improve global health outcomes.
Contact Information
Corporate Office
- United Arab Emirates
Corporate Office
- United Arab Emirates
DiabTec Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
DiabTec Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
DiabTec FAQs
-
Where is DiabTec headquartered?
DiabTec is headquartered in United Arab Emirates.
-
What industry is DiabTec in?
DiabTec’s primary industry is Other Devices and Supplies.
-
Is DiabTec a private or public company?
DiabTec is a Private company.
-
What is DiabTec’s current revenue?
The current revenue for DiabTec is .
-
Who are DiabTec’s investors?
Gulf Pharmaceutical Industries has invested in DiabTec.
-
When was DiabTec acquired?
DiabTec was acquired on 19-Dec-2024.
-
Who acquired DiabTec?
DiabTec was acquired by KELIX Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process